US spent $3B on DMD treatments as confirmatory studies still underway, JAMA paper says
The US has so far doled out about $3 billion on three of Sarepta Therapeutics’ therapies for Duchenne muscular dystrophy, even as all three of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
